Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.75 |
| ▸ | USP2 | O75604 | 6/20 | 0.70 |
| ▸ | LMNA | P02545 | 4/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | HTT | P42858 | 6/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.67 |
| ▸ | TP53 | P04637 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16639754 | 0.92 | SMN1; SMN2 (0.80) | SMN1; SMN2ALDH1A1USP2LMNAKDM4E | |
| SCHEMBL10261335 | 0.88 | SMN1; SMN2 (0.86) | SMN1; SMN2ALDH1A1USP2LMNAKDM4E | |
| SCHEMBL10259647 | 0.87 | ALDH1A1 (0.98) | SMN1; SMN2ALDH1A1USP2LMNAKDM4E | |
| SCHEMBL8275548 | 0.87 | ALDH1A1 (0.98) | SMN1; SMN2ALDH1A1USP2LMNAKDM4E | |
| SCHEMBL8276984 | 0.81 | TDP1 (0.80) | SMN1; SMN2ALDH1A1USP2LMNAKDM4E | |
| SCHEMBL16639766 | 0.81 | NAMPT (0.71) | SMN1; SMN2TP53 | |
| SCHEMBL16639798 | 0.79 | SMN1; SMN2 (0.78) | SMN1; SMN2ALDH1A1USP2LMNAKDM4E | |
| SCHEMBL10260221 | 0.79 | SMN1; SMN2 (0.86) | SMN1; SMN2ALDH1A1USP2LMNAKDM4E | |
| SCHEMBL8276991 | 0.78 | MAPT (0.73) | SMN1; SMN2ALDH1A1LMNAKDM4EHTT | |
| SCHEMBL10260323 | 0.78 | MAPT (0.73) | SMN1; SMN2ALDH1A1LMNAKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10696692-B2 | Amido-benzyl sulfone and sulfoxide derivates | Valo Health, LLC | 2020-06-30 | — | — | US | disclosed |
| US-20150104384-A1 | AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES | VALO HEALTH, INC. | 2015-04-16 | — | — | US | disclosed |
| US-20150104384-A1 | AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES | VALO HEALTH, INC. | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696692-B2 | Amido-benzyl sulfone and sulfoxide derivates | STS, SQOR, SULT1E1 | SMN1; SMN2 346/4885ALDH1A1 2853/4885USP2 3157/4885 |
| US-20150104384-A1 | AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES | STS, SULT1E1, CBS | SMN1; SMN2 616/4885ALDH1A1 2737/4885USP2 3457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.